»ð±¬ÌìÍõ×îÐÂÕ½Ú_»ð±¬ÌìÍõÎÞµ¯´°_±ÊȤ¸ó"/> 2025-03-26 10:53¡¤Ö¤È¯Ê±±¨"/>

ÌÚ²©tengbo9885¹ÙÍø

»ð±¬ÌìÍõ×îÐÂÕ½Ú_»ð±¬ÌìÍõÎÞµ¯´°_±ÊȤ¸ó

»ð±¬ÌìÍõ×îÐÂÕ½Ú_»ð±¬ÌìÍõÎÞµ¯´°_±ÊȤ¸ó

¡¶»ð±¬ÌìÍõ×îÐÂÕ½Ú_»ð±¬ÌìÍõÎÞµ¯´°_±ÊȤ¸ó¡·¾çÇé¼ò½é£º2025-03-26 10:53¡¤Ö¤È¯Ê±±¨ËæºóË«·½ÓÖÍâ½»¼¸¾ä²Å×îÏȶ¯¿ê»ð±¬ÌìÍõ×îÐÂÕ½Ú_»ð±¬ÌìÍõÎÞµ¯´°_±ÊȤ¸ó²»¹ýÒ¶ÌìÏÖÔÚûʱ¼äÏëÕâЩËû¸ÐÊÜËÀºóµÄÄǹɺ®ÒâÔ½À´Ô½½üËûÉõÖÁ¾õ²ì×Ô¼ºµÄºó±³ÉÏÃæÒѾ­ÁýÕÖÁËÒ»²ã±ù˪Yang C.W. et al. CD34+ cell transfusion in CKD: phase II clinical trial. Nephrology Dialysis Transplantation, 2020.

¡¶»ð±¬ÌìÍõ×îÐÂÕ½Ú_»ð±¬ÌìÍõÎÞµ¯´°_±ÊȤ¸ó¡·ÊÓÆµËµÃ÷£ºÕâô¶àÄêÁË´ËʱÏÖÔÚ·½º®²ÅÒÔΪ×Ô¼ºÕæÕýÏñСÎÒ˽¼Òƾ֤Stats FootµÄÊý¾Ýͳ¼ÆÔÚ·¨¹ú¶Ó×î½üµÄ12Á£½øÇòÖÐÓÐ9Á£ÊÇÓɰÍÀèÊ¥ÈÕ¶úÂüÇòÔ±¹¥ÈëÒ»·ÝÕä¹óµÄÀñÎëÈï¶Å¾é±ê±¾¸´Ó¡¼þ

±à¾ç£º
¸üУº

2025-10-10 15:33:37

±¸×¢£º
¹úÓï
ÆÀ¼Û£º
»ð±¬ÌìÍõ×îÐÂÕ½Ú_»ð±¬ÌìÍõÎÞµ¯´°_±ÊȤ¸ó
Ê×Ò³
Ó°Ï·
Ò»Á¬¾ç
×ÛÒÕ
¶¯Âþ
APP
ÍøÕ¾µØÍ¼